NDC codes

406279 NDC codes with hospital pricing data in the network.

• NDC 6851652168 — Human albumin 25% intravenous solutionAI (25 hospitals, 24–240 samples)
• NDC 6851652169 — Human albumin 25% intravenous solutionAI (42 hospitals, 24–240 samples)
• NDC 6898264301 — Human albumin 25% intravenous solutionAI (48 hospitals, 24–240 samples)
• NDC 6898264302 — Human albumin 25% intravenous solutionAI (43 hospitals, 24–240 samples)
• NDC 6937490205 — Neostigmine methylsulfate 1 mg/mL IV syringeAI (46 hospitals, 24–240 samples)
• NDC 7006980601 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTIONAI (42 hospitals, 24–240 samples)
• NDC 7070017222 — Neostigmine methylsulfate 1 mg/mL injectionAI (44 hospitals, 24–240 samples)
• NDC 7070017223 — Neostigmine methylsulfate 1 mg/mL injectionAI (43 hospitals, 24–240 samples)
• NDC 7101920512 — Neostigmine methylsulfate injection, 1 mg/mLAI (20 hospitals, 24–240 samples)
• NDC 7101920514 — Neostigmine methylsulfate 1 mg/mL injectionAI (20 hospitals, 24–240 samples)
• NDC 7128850110 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTIONAI (42 hospitals, 24–240 samples)
• NDC 7128850111 — Neostigmine methylsulfate 1 mg/mL injectionAI (42 hospitals, 24–240 samples)
• NDC 7604538313 — Neostigmine methylsulfate 3 mg/3 mL injection syringeAI (51 hospitals, 24–240 samples)
• NDC 7604538330 — Neostigmine methylsulfate 1 mg/mL injection syringeAI (51 hospitals, 24–240 samples)
• NDC 7612579210 — Human albumin 25% intravenous solutionAI (25 hospitals, 24–240 samples)
• NDC 7612579211 — Human albumin 25% intravenous solutionAI (24 hospitals, 24–240 samples)
• NDC 7612579225 — Human albumin 25% intravenous solutionAI (24 hospitals, 24–240 samples)
• NDC 7612579226 — Human albumin 25% intravenous solutionAI (21 hospitals, 24–240 samples)
• NDC 25021-0190-10 — Micafungin sodium injection 50 mgAI (279 hospitals, 123–240 samples)
• NDC 43066-0041-01 — Hydralazine hydrochloride injection 20 mg/mLAI (132 hospitals, 24–240 samples)
• NDC 43066-0041-25 — Hydralazine injection 20 mgAI (94 hospitals, 24–240 samples)
• NDC 50242-0176-01 — Tenecteplase injection kit 50 mgAI (526 hospitals, 24–240 samples)
• NDC 63323-0596-16 — Glucagon injection, 1 mgAI (191 hospitals, 24–240 samples)
• NDC 70860-0208-51 — DOXORUBICIN 2 MG/ML INTRAVENOUS SOLUTIONAI (82 hospitals, 240 samples)
• NDC 74527-0022-01 — Margetuximab injection, 10 mL vialAI (237 hospitals, 204–240 samples)
• NDC 641623101 — Hydralazine 20 mg/mL injection vialAI (86 hospitals, 24–240 samples)
• NDC 641623125 — Hydralazine 20 mg/mL injectionAI (66 hospitals, 24–240 samples)
• NDC 67457-0645-00 — Naloxone injection 0.4 mg per mLAI (120 hospitals, 24–240 samples)
• NDC 64208-2510-06 — Human albumin 5% intravenous solutionAI (65 hospitals, 24–240 samples)
• NDC 71266-5075-01 — Vancomycin premixed in saline, 1.5 gAI (28 hospitals, 24–240 samples)
• NDC 70121-1236-01 — CLOFARABINE 1 MG/ML INTRAVENOUS SOLUTIONAI (145 hospitals, 240 samples)
• NDC 67457-0859-30 — Adenosine injection 3 mg/mL, 2 mL vialAI (73 hospitals, 213–240 samples)
• NDC 08888-8878-46 — Piflufolastat F-18 injection (radioactive imaging agent)AI (17 hospitals, 213–240 samples)
• NDC 99999-2565-55 — FENTANYL (PF) 50 MCG/ML INTRAVEOUS INFUSION FOR INTRAOP (2 hospitals, 24–240 samples)
• NDC 00517-2610-25 — Magnesium sulfate injection, 500 mg/mL vialAI (36 hospitals, 24–240 samples)
• NDC 00338-9586-24 — Lidocaine hydrochloride in dextrose injectionAI (13 hospitals, 24–240 samples)
• NDC 66647-6065-25 — Neostigmine methylsulfate injection syringeAI (22 hospitals, 24–240 samples)
• NDC 09999-4025-01 — VANCOMYCIN 1500 MG/250 ML NS PREMIX (SIMPLE) (11 hospitals, 24–240 samples)
• NDC 09999-9007-75 — AMPICILLIN-SULBACTAM (30-15 MG/ML) IN NS PEDS/NICU (11 hospitals, 24–240 samples)
• NDC 99999-9016-22 — SODIUM IODIDE I-123 7.4 MBQ PO CAPS (A9509) (11 hospitals, 24–240 samples)
• NDC 09991-2621-00 — Methotrexate eye injectionAI (23 hospitals, 24–240 samples)
• NDC 43598084858A — ZIPRASIDONE 20MG INJECTION (14 hospitals, 24–240 samples)
• NDC 517234099 — Venofer iron sucrose intravenous iron infusionAI (51 hospitals, 113–239 samples)
• NDC 68001-0265-25 — Etoposide 100 mg/5 mL intravenous solutionAI (148 hospitals, 202–238 samples)
• NDC 00409-1135-99 — MORPHINE 150MG/30ML PCA INJ (1 hospital, 238 samples)
• NDC 00641-6190-01 — Midazolam injection 5 mg/mL, 10 mL vialAI (100 hospitals, 175–238 samples)
• NDC 43547-0640-25 — Glycopyrrolate 0.4 mg/2 mL injectionAI (89 hospitals, 121–238 samples)
• NDC 63323096510A — POTASSIUM CHLORIDE 20mEq 10 ML (3 hospitals, 67–238 samples)
• NDC 00143-9273-01 — Dihydroergotamine mesylate injection, 1 mg/mLAI (298 hospitals, 66–237 samples)
• NDC 25021-0703-60 — Sumatriptan injection 6 mg per 0.5 mLAI (97 hospitals, 66–237 samples)